Corvus Pharmaceuticals Inc (CRVS)
1.83
+0.10
(+5.78%)
USD |
NASDAQ |
May 03, 11:48
Corvus Pharmaceuticals Cash from Financing (Quarterly): 0.00 for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.335M |
| June 30, 2023 | 7.516M |
| March 31, 2023 | 0.004M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.018M |
| September 30, 2021 | 18.33M |
| June 30, 2021 | 11.22M |
| March 31, 2021 | 32.59M |
| December 31, 2020 | 1.223M |
| September 30, 2020 | 0.064M |
| June 30, 2020 | 0.023M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.002M |
| September 30, 2019 | 0.016M |
| Date | Value |
|---|---|
| June 30, 2019 | 0.005M |
| March 31, 2019 | 0.001M |
| December 31, 2018 | 0.172M |
| September 30, 2018 | 0.166M |
| June 30, 2018 | 0.048M |
| March 31, 2018 | 64.88M |
| December 31, 2017 | 1.308M |
| September 30, 2017 | 0.126M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.008M |
| December 31, 2016 | 0.003M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 7.012M |
| March 31, 2016 | 64.34M |
| December 31, 2015 | -0.729M |
| September 30, 2015 | 74.90M |
| June 30, 2015 | 16.74M |
| March 31, 2015 | 4.037M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
32.59M
Maximum
Mar 2021
3.755M
Average
0.016M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.999M |
| Arbutus Biopharma Corp | 3.807M |
| Oragenics Inc | -0.1806M |
| Relmada Therapeutics Inc | -0.0985M |
| MAIA Biotechnology Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.167M |
| Cash from Investing (Quarterly) | -2.318M |
| Free Cash Flow | -23.97M |
| Free Cash Flow Per Share (Quarterly) | -0.1053 |
| Free Cash Flow Yield | -27.28% |